The global crisis surrounding the novel coronavirus 2019–nCoV, commonly known as the COVID-19 coronavirus, is at the forefront of everyone’s mind. It has affected the lives and the work of people around the world, including chemists. Yet chemists are also at the forefront of the fight to understand, contain, treat, and eventually defeat the disease. The American Chemical Society takes this threat seriously and remains committed to supporting chemists during this difficult time as part of its mission to advance the broader chemistry enterprise around the world. Below is a collection of news, research, and resources for chemists related to the COVID-19 coronavirus pandemic, courtesy of ACS Publications.
Please bookmark this page and share it with your professional network, as it will be updated with new information and chemistry resources related to the pandemic as they become available.
Frequently Asked Questions
Click below to read answers to common questions about ACS Publications’ operations during the COVID-19 crisis.
ACS Publications Response to the Pandemic
What is ACS doing to ensure that coronavirus related research is available?
ACS has made all coronavirus-related research published in our 60+ portfolio of journals open access and free-to-read since learning of the novel coronavirus outbreak. The most effective way to access this research is through this virtual issue, which is being updated regularly as new articles are published. Additionally, ACS has made all COVID-19 related research published in ACS journals freely and immediately available in the National Institutes of Health PubMed and World Health Organization (WHO) databases.
How is ACS supporting the federal and global COVID-19 response?
As the world’s largest scientific society, ACS is doing everything possible to aid in the global and federal response to the pandemic. Information about ACS efforts in this area is available on the ACS resources webpage. In addition to enabling free access to all coronavirus-related research, CAS, a division of the American Chemical Society, is reaching out to offer its considerable expertise to organizations investing their efforts toward vaccine and therapeutic research as they evaluate the means to combat COVID-19. This assistance, offered at no charge, might involve helping researchers get needed answers or analyses quickly, providing access to CAS solutions, satisfying requests for custom-curated data sets relevant to a target of interest or collaborating with our CAS scientists on a challenging formulations problem, among others. You can contact CAS at the CAS Customer Center.
Does ACS have any resources for families teaching children or young adults about science and chemistry at home?
ACS has made resources available to help in teaching high school, middle school, and elementary school students. The American Association of Chemistry Teachers has also unlocked resources for families learning from home. Additional educational resources can be found on ACS’ Educate resource page.
I’m a professor teaching remotely. Are there any resources I can review?
ACS’s member magazine, Chemical & Engineering News (C&EN) has compiled useful tips for teaching online. The Journal of Chemical Education has also created an open-access, free-to-read collection of articles on this topic. Additional resources can be found on the ACS Educate resource page.
Does ACS have any materials for non-chemists who would like to learn more about the pandemic and how it affects our lives?
C&EN has made all of its coverage of the coronavirus pandemic open access and free-to-read for all. C&EN’s reporting includes coverage of the scientific advances in fighting the virus and news about the impact of the pandemic on universities, labs, and industry.
To learn more about the chemistry behind coronavirus, how vaccines are made, and how materials like soap and hand sanitizer work to fight the virus, visit, and subscribe to ACS’s Reactions YouTube channel. Additional materials can be found on ACS’ Communicate resource page.
Publishing and Journal Activity
Will there be delays in the publication of my article during the pandemic?
At the moment, we are not experiencing any delays in the publication process, but individual circumstances may lead to delays in peer review. If you have questions about the timeline for publication of an article, contact your journal’s editorial office.
What should I do if I need additional time to submit revisions to an article?
If you need more time, contact your journal’s editorial office and explain your request. We’ve communicated the need to be flexible during this unprecedented time to all ACS editors, who understand that authors may be under challenging circumstances.
Will the release of any ACS journals be delayed?
We are doing everything we can to minimize any journal disruptions, and at this time, we expect no delay in the release of any ACS journal articles or issues. If this should change, we will communicate updates to our subscribers and authors.
How can I submit my research quickly?
Uploading your research to ChemRxiv is the fastest way to make your work public. ChemRxiv is a free-to-use service for disseminating unpublished preprints in chemistry and related areas. Preprints are easily searchable and free to read, many with licenses that permit reuse. Uploading your manuscript to ChemRxiv prior to submitting it to a journal for peer review is the quickest way to document your research and make it available to the chemistry community. Please note that while ChemRxiv carries out checks for problematic content, the curators there do not carry out peer review.
As many universities and labs have closed, what considerations should I make when performing a peer review?
We’ve asked our peer reviewers and editors to refrain from requesting additional experiments except when absolutely necessary, as doing so during this time may delay publication. Our journal editorial offices are aware of the difficulties that researchers face when additional lab work is requested; they are carefully evaluating all requests for any additional experimentation from peer reviewers at this time.
I am able to peer review. How can I let editors know of my availability?
We encourage you to accept invitations to peer review, and/or contact journal editorial offices in your field and let them know of your availability. Our peer reviewers are vital to the publication process, so if you find yourself with time, ACS journal editors will no doubt appreciate your expertise.
I thought I had time to review an article, but my circumstances have changed. What should I do?
We understand that individual circumstances are changing on a daily basis. We appreciate your commitment to peer review, but if you are unable to complete a review, please contact the journal editorial office and explain that you are no longer available. You will still be contacted for peer review requests in the future unless you wish otherwise.
Remote Access to ACS Publications
My university is closed. How can I access ACS Publications without using my university’s VPN?
ACS Publications has a variety of options for how you can access articles remotely. Visit our remote access resource page to learn about options for you and for your institution.
I still have access to my university network but plan to begin working and/or studying remotely soon. How can I maintain access to ACS Publications when not on their network?
You can pair a device while on your university network and maintain access to ACS Publications while working remotely. To pair your device, follow the instructions here.
ACS has enabled “federated authentication” for my university. What is federated authentication?
Federated authentication is a method for allowing members of one organization to use their authentication credentials to access a web application of another organization. This means that students or researchers working off-campus can use their campus credentials to access ACS Publications content without the need for a VPN.
Is Patrons’ privacy protected when logging in with federated authentication?
Institutions are in control over the information that is released about their users. ACS Publications does not require any personally identifiable information (e.g. name or email address). In addition, as a division of the American Chemical Society, we are governed by the Society’s overarching privacy policy, available here.
Will IP authentication and COUNTER reports be affected?
No, enabling remote access via federated authentication does not impact the use of IP address authentication for any users directly connected to the campus network or remotely connected via a VPN/proxy server. In addition, enabling remote access via federated authentication will have no impact on COUNTER reports. COUNTER reports will include usage while on-campus, off-campus, and connected via a VPN/proxy server, or off-campus using federated authentication.
Federated authentication is not yet available through my university. Can my school be added?
The list of institutions that have had federated authentication enabled is growing rapidly. See a full list and search for your school. We are continuing to add new universities every day, so please check back regularly if you don’t see your institution yet.
Take a Two-Hour On-Demand Course from ACS Publications:
Get Access to COVID-19 Coronavirus Research from ACS Publications
***
Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases
***
Overview of Research on the Fate and Behavior of Enveloped Viruses in the Environment
***
A Collection of COVID-19 Research on ChemRxiv
***
Resources for Teaching Your Chemistry Class Online
Remote Access for Researchers
Visit our remote access resource page to learn more and to get instructions on SeamlessAccess and device pairing. If you need additional help or guidance, please email us at acs_pubs_assist@acs.org.
ACS Publications Call for Papers for COVID-19 & Related Research Topics
ACS Publications is committed to rapidly communicating urgent developments in characterizing, preventing, and treating the novel coronavirus (2019-nCoV) or the disease it causes, COVID-19. As part of that commitment, we’re working to assist anyone whose research relates to COVID-19 to publish and share their results as quickly as possible.
We invite you to submit your COVID-19 or coronavirus-related manuscript to one of our journals.
Consideration for COVID-19 Manuscripts & Published Articles
Due to the unique nature of the current situation, ACS Publications has some special measures in place for handling manuscripts and published articles related to COVID-19/coronavirus:
- For a limited time, free editing services are available for all manuscripts related to COVID-19/coronavirus. Visit ACS Authoring Services to learn more.
- COVID-19/coronavirus-related articles included in the Chemistry in Coronavirus Research Virtual Issue are free to read through the end of 2020.
- ACS Publications is sharing all articles related to COVID-19/coronavirus with the World Health Organization (WHO) immediately upon publication, for inclusion in the WHO COVID-19 research database.
Use a Preprint to Share Your Results Even Faster
ACS also welcomes submissions to the preprint server ChemRxiv.
When you post a draft of your manuscript on ChemRxiv, you can share your results with the community and get feedback ahead of formal peer review and publication. You can also use ChemRxiv’s Direct Journal Transfer feature to submit a posted preprint to an established journal for editorial consideration and peer review.
All ACS journals accept manuscripts that have been previously published on ChemRxiv.
Special Issue Calls for Papers
Specific ACS Publications journals are inviting manuscript submissions for Special Issues:
Environmental Science & Technology
ES&T Special Issue Call for Papers: Environmental Transmission and Control of COVID-19
Journal of Chemical Education
Call for Papers: Special Issue on Insights Gained While Teaching Chemistry in the Time of COVID-19
Journal of Proteome Research
Call for Papers: Special Issue on Proteomics and its Application in Pandemic Diseases
A Message for Authors and Reviewers
For Authors
During these unprecedented times, ACS remains fully committed to supporting our authors. In particular, we want to remain flexible with deadlines for revisions and other requests. Please let your journal’s editorial office know if you need additional time to work on a manuscript revision or run into any other challenges with preparing your manuscript. We are happy to work with you!
To support the publication of your research, ACS staff and Editors are working carefully to ensure that journal operations continue with as little disruption as possible. However, given the challenges presented by the COVID-19 outbreak, you may experience delays in the event that reviewers or editors need more time to complete evaluations of your manuscript. We appreciate your understanding that others involved in the publishing process are experiencing many of the same challenges. Posting a preprint of your research on ChemRxiv is one way to help your work reach its audience as rapidly as possible.
For Reviewers
The current global crisis proves that now more than ever, the contributions of scientists are vital. We appreciate the efforts of our reviewers, as their work allows critical research to continue to be published. However, we completely understand that taking the time to review a manuscript is not always possible, especially at this time. If you receive a review invitation, consider the timeline requested and feel free to decline if it isn’t feasible for you. If you’ve accepted an invitation to review and your situation no longer allows you the time necessary to do so, please contact the journal office as soon as possible and explain that you are no longer able to review. We would encourage you to help the editor by recommending an alternate reviewer whenever possible.
If you decline an invitation to review, our editors will contact you again for future review opportunities unless you indicate that you are not interested. Declining a review during this time does not mean that you will be excluded from future review opportunities.
For others, you may find that you have some additional time available at the moment. In these cases, please accept invitations to review, and let journal offices in your area of expertise know if you are available for more review assignments. Hard-working editors will appreciate knowing you are willing and able to provide your expert feedback!
Finally, given that many researchers are not able to visit their labs during this time, please carefully consider any request for additional experimentation as doing so can further delay publications. We ask that you only recommend experiments if they are essential for publication, and clearly differentiate for the editor between required additions (e.g., critical controls) and suggestions that would strengthen the work but should not stand in the way of publication.
Share Your Posters and Presentations Online
Read Ongoing Coverage of the COVID-19 Coronavirus
Watch a Reactions Video about the Chemistry of How Soap Affects Viruses Like COVID-19
News and Updates about the COVID-19 Coronavirus from ACS
Update to Our Reader, Reviewer, and Author Communities—April 2020
ACS Catalysis in the Time of COVID-19
ACS Chemical Biology: Fighting the Coronavirus Outbreak
American Chemical Society terminates its Philadelphia spring national meeting
Add a Comment
132 Comments
Merid Tessema
4:50 amI would be too much happy for the information
Miroslav Vrvić
10:00 pmAlso, I would be too satisfied with information!
LIU Peng
1:19 amThanks for the valuable informations from ACS.
Huajun Huang
11:56 pmI have to carefully consider whether to delay my revision or not. Some characterizations in my institution cannot be done.
Jin Schreiner
10:50 amThan you
Kiumars Bahrami
1:22 pmThank you for your attention to this matter!
Shabirqureshi
5:00 amI think in this situation only practically proved (authentic) papers need to be published and moreover all focus needs to be inclined towards COVID-19 Pandemic drug/Vaccine ,both through conventional and Natural means.. This should be ethically Antiviral but not an Antimalarial drug .
Thanks
Engr Tunji John Erinle
Response to Shabirqureshi 9:28 amIt is a good idea research topic to work upon
Ralph Nelson
10:48 pmHow can a retired (60-year) ACS member (no longer an employee of a campus or company or agency) get access to the COVID-19 Resource Center? There seems to be no provision for this on the sign-up page.
acs.axial
Response to Ralph Nelson 3:41 pmThe resources linked to on this page are all free to read.
Kalyanashis Jana
3:20 pmThanks
Unnat Pandit
8:19 pmCovid-19 is global crisis, the initiative taken up by ACS to give access to rich scientific content made available on same will be useful to research and embark novel ways of scientific discoveries in managing infectious diseases.
Sougata Sarkar
3:50 pmA very good initiative from ACS. Due respect and regards….
PEDRO LANA GASTELOIS
11:21 pmthanks for the opportunity
P.Manikyamba
7:55 amThanks for the valuable information
Qusay
5:52 amIt is valuable information, Thanks to ACS
Huarong Nie
2:36 amThank you for your attention to this matter!
Yuanjun Yang
10:52 amBless! Any difficulties will pass away soon.
Mohammad Hadi Ghatee
11:40 amThank you for your attention to this matter and for linking people together.
jamilu aliyu
1:18 pmI have satisfied with information you provided
jamilu aliyu
1:55 pmThank you for the current research that provides regarding COVID-19 Pandemic drug/Vaccine,and I have too much happy for the information and satisfied as weII,best regards ACS
minakshi prasad
4:15 pmHi,
Are there any APC or article submission charges for submission of Coronavirus articles?
Thanks
Minakshi
acs.axial
Response to minakshi prasad 5:17 pmAPC policies do not vary based on subject matter. You can read about ACS’ open access policies here: https://acsopenaccess.org/
Jun Yin
7:53 pmThanks for the valuable informations from ACS.
hui wang
4:37 amThanks
Pranav Shrivastav
9:14 amThis is indeed an invaluable information, the need of the hour. Thank you ACS
Haryanto Ph.D.
2:47 pmThanks for this valuable information
Xiaoming
5:01 amThank you for your attention to this matter!
Ali GHanadzadeh Gilani
3:09 amThank you so much for your valuable information and concern
Fangzhi Huang
12:31 amThanks for the valuable informations from ACS
pradeesh narayanan
8:25 pmthank you management team of ACS
Neelu Chouhan
5:32 pmSupport provided by ACS in this COVID time is highly appreciated
IFEDI EMMANUEL NNAM
1:38 amThank you for your attention to this matter
Liang Yan
2:35 amThank you for this valuable information from ACS!
Parimal Paul
3:54 amThanks for taking initiative for this important research area. The entire world is now looking for a solution for this pandemic diseases.
Vishal Gurumukhi
3:49 amyes this is global crisis. so I would like to get information. thank you.
Xiaoping Wang
8:46 pmThank you for the platform. I hope all over the countries could get through the pandemic and wish our work submitted to ACS could help fight against the crisis.
Guojun Zha
2:33 amThank you for your attention!
S.K. Shukla
12:48 amMany many thanks for information
Viktoria
8:49 amThank You for your kindness
Jianguo Sun
8:16 amA very good initiative from ACS. thanks!support!!
Antonio Aguilar
2:30 pmThank you for this initiative
Chhanda Charan Danta
7:42 amMany Thanks, ACS for this good effort.
Gordon Cragg
9:45 amThanks to ACS for this valuable service to the world chemistry community!
William R Kem
11:50 amThanks much!
Sanjeev Reddy
10:39 pmGood initiative towards the current crisis facing all individuals across the globe.
Liu Cao
10:17 pmThanks. hope that the epidemic will soon end.
Maoshen Chen
2:32 amThank you
Haitao
9:56 pmThanks for the valuable resources.
Fernando C. Oliveira
3:13 pmThank you for this valuable information from ACS.
Bing Yan
11:49 amThanks for your useful information from ACS.
Ajaya Bhattarai
7:40 pmgood ideas to update the news about COVID-19.
Dharma Khanal
11:24 amVery informative the latest research about COVID 19
Fabio Aricò
8:41 amthank you for the information.
Dr RAJENDRA PRASAD VASANTA
5:02 amA very good initiative from American Chemical Society, Due respect & regards and Thank you for your attention in this Issue.
Amy Deveau
6:38 pmThank you for the valuable information.
Best,
A. Deveau
Veronique Lee
7:07 pmThank you!
Wenju Xu
10:06 amThanks for the precious information from ACS.
ashrafsadat ghasemi
3:44 pmThank you
Francisco Barrantes
1:43 pmOur review: “While we wait for a vaccine: Why not think about available drugs? has appeared in Frontiers in Physiology, section on Clinical and Translational Physiology. Here is the link: https://doi.org/10.3389/fphys.2020.00820
Dipankar Chakravorty
1:55 amThank you for your most thoughtful comments and actions
Dipankar Chakravorty
Response to Dipankar Chakravorty 1:59 amThank you for the most useful information
BY HAN
10:25 pmThanks for the valuable informations from ACS.
Guojun Zha
8:07 amI am glad to know these informations
Guoqin Liu
9:50 amIt is valuable information, Thanks to ACS
Jingming Gong
9:42 pmThank you very much for providing the special platform in ACS. Let all of us gather together and contribute our efforts to explore and understand more about the COVID-19 Coronavirus.
HILDA REYNA INES ROLDAN ARMASTHANKS
4:22 pmTHANKS
Vicente
12:19 pmGreat for invaluable information
Luxiang Wang
7:57 amThanks for the valuable information.
Deyun Wang
9:18 pmThank for the valuable informations from ACS.
H Namazi
12:17 amThanks for the valuable informations from ACS
Shubhrat Maheshwari
11:32 amI am keenly interested to publish review article related to Covid-19 in your publication.
Please hush if you don’t know what you’re talking about – lauralanni
1:31 am[…] COVID research papers […]
Manitaslake
3:30 amThat’s a really helpful information for all of us, thank you ser
chang ye
1:36 amI would be too much happy for the information
Christopher Uchechukwu Sonde
4:38 amInteresting!
Jinyeol, Kim
7:18 amThinks for the valuable information
Chittaranjan Sinha
12:22 pmThis mental and intellectual support inspires to get a route to fight this pandemic Covid 19. Thank you ACS.
shexuefeng-78
5:25 amI will take more attention to this topic.
Haibing He
2:50 amThanks for the valuable informations.
Shital Amin
6:51 amThank you very much for the valuable information from ACS.
Weiqiang Zhou
10:05 pmThanks for the valuable informations from ACS.
Vahid Eslamimanesh
10:49 amThanks for invaluable Publication in the world of science & Technology.
Best Regards
Xinli Song
4:39 amThanks for the valuable informations from ACS.
Jianfei Wu
3:17 amThanks for the initiative from ACS and I would be very happy to receive this information.
Imman
9:34 amThank you
Fei Ling
10:52 pmThank you for your attention to this matter!
Jinxin Zou
1:57 amThanks for the valuable informations of the COVID-19 Coronavirus from ACS.
Wenheng Jing
9:02 amThank you for the information and I hope the pandemic could be got through. Best regards ACS.
Wenju Xu
9:57 pmMany Thanks!
Cheng Gang Li
8:48 pmThanks for the valuable informations from ACS.
Seyyed Amir Siadati
2:32 pmThank you.
I hope the chemical societies, and the ISI system practically help to find the COVID-19 treatment.
Zhanmin Liu
4:49 amI am very happy to know that the journal’s editorial office adopt a flexible and effective measure to deal with covid-19 crisis to do their best to meet authors and reviewers request.
Jiusheng Li
10:17 pmThanks for kindly reminder
Xia Wang
4:10 amThank you for your attention to this matter!
Yanping Zhao
10:01 amThank you for sharing information about COVID 19.
Ezeh Marian Isioma
11:08 pmThanks for this vital information and for your continual assistance and support. This will go a long way to encourage young researchers like me.
guangqiang liu
1:59 amThanks for the valuable informations from ACS.
Xiaoshan Zhang
10:29 amThe valuable information from ACS is important for us.
P.V Hemalatha
1:15 amIt is a very good effort by ACS for promoting research in covid 19
Shuangfang Lu
10:19 amThanks for the valuable informations from ACS.
Jun Lu
10:07 amThank u so much for all these valuable information from ACS
Dr.P.Tamizhdurai
12:56 amI would be too much happy for the information
Liu
2:25 amIt is valuable information, Thanks to ACS
Tan Yebang
9:46 pmThanks for the valuable information.
Biserka Gržeta
7:03 amThank you very much, I do appreciate the valuable informations from ACS.
Hongliang Li
5:44 amThanks for the valuable informations.
xiangyang Zhu
1:52 amThanks for the valuable informations from ACS.
Taohong
Response to xiangyang Zhu 9:15 pmThanks for the valuable informations from ACS.
Bekir
12:53 pmThank you very much for your information about interesting and important area
Linlin Wu
7:16 pmThank you
Linlin Wu
7:17 pmThank you for the information.
LAVANYA GOPALA
9:09 pmIt is very helpful for my submission
Zhao Wei
10:24 pmThanks for the valuable informations from ACS.
Guodong Hu
2:43 amThanks for the valuable informations from ACS.
Liqin Chai
10:59 pmThanks
Liqin Chai
11:01 pmThanks for the information
Patricio Ruiz
4:39 amThanks a lot
Parbat Subba.
11:05 pmAppreciate your efforts.
Bharat Aggarwal
2:03 pmHighly informative & educational!
Tuanjie Li
3:03 amThank you very much.
Herbert Roesky
5:02 amThank you very much for your valuable information.
Guoxiang Wang
12:06 amThanks very much
Pan Lei
2:18 amThank you.
Tan Zhaozhao
2:27 amThank you for your understanding
Yincheng Chang
5:21 amThanks for the valuable informations from ACS.
aipeng jiang
2:44 amThanks for the valuable informations from ACS.
Yanqing Zu
9:46 pmThanks for the valuable informations from ACS.
Yazhuo Shang
9:31 pmThanks for the valuable information from ACS
LinhNguyen
3:52 amThanks for the valuable informations from ACS.
Yinan Wang
4:48 amIt is hoped that scholars will work together to defeat the virus as soon as possible
Yadong Xu
8:38 amThanks for the information provided by ACS.